DYN
Dyne Therapeutics Inc.
$15.45
+$1.42(+10.12%)
49
Overall
60
Value
54
Tech
34
Quality
Market Cap
$1.87B
Volume
2.20M
52W Range
$6.36 - $35.90
Target Price
$35.35
EPS Estimates Overview
| Current Quarter | $-0.81 | Next Quarter | $-0.79 |
| Current Year | $-3.57 | Next Year | $-3.36 |
| QoQ Growth | +2.5% | YoY Growth | +5.9% |
| 3Y EPS CAGR | N/A | Target Price | $35.35 |
| Consensus | Buy | Upside | +128.8% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DYN | $15.45 | +10.1% | 2.20M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |